{"context":{"query":">>hgnc>>gencc","source_dataset":"hgnc","target_dataset":"gencc"},"stats":{"queried":1,"total":39,"mapped":1},"pagination":{"has_next":false},"schema":"id|gene_symbol|disease_title|classification_title|moi_title|submitter_title","mappings":[{"input":"HGNC:3690","source":"HGNC:3690|fibroblast growth factor receptor 3","targets":["GENCC_000101-HGNC_3690-OMIM_100800-HP_0000006-GENCC_100001|FGFR3|achondroplasia|Definitive|Autosomal dominant|Ambry Genetics","GENCC_000101-HGNC_3690-OMIM_146000-HP_0000006-GENCC_100002|FGFR3|hypochondroplasia|Strong|Autosomal dominant|Ambry Genetics","GENCC_000101-HGNC_3690-OMIM_187600-HP_0000006-GENCC_100002|FGFR3|thanatophoric dysplasia type 1|Strong|Autosomal dominant|Ambry Genetics","GENCC_000101-HGNC_3690-OMIM_602849-HP_0000006-GENCC_100001|FGFR3|Muenke syndrome|Definitive|Autosomal dominant|Ambry Genetics","GENCC_000101-HGNC_3690-OMIM_610474-HP_0000007-GENCC_100003|FGFR3|camptodactyly-tall stature-scoliosis-hearing loss syndrome|Moderate|Autosomal recessive|Ambry Genetics","GENCC_000101-HGNC_3690-OMIM_612247-HP_0000006-GENCC_100001|FGFR3|Crouzon syndrome-acanthosis nigricans syndrome|Definitive|Autosomal dominant|Ambry Genetics","GENCC_000104-HGNC_3690-OMIM_100800-HP_0000006-GENCC_100002|FGFR3|achondroplasia|Strong|Autosomal dominant|Genomics England PanelApp","GENCC_000104-HGNC_3690-OMIM_187600-HP_0000006-GENCC_100002|FGFR3|thanatophoric dysplasia type 1|Strong|Autosomal dominant|Genomics England PanelApp","GENCC_000104-HGNC_3690-OMIM_187601-HP_0000006-GENCC_100002|FGFR3|thanatophoric dysplasia type 2|Strong|Autosomal dominant|Genomics England PanelApp","GENCC_000104-HGNC_3690-OMIM_602849-HP_0000006-GENCC_100002|FGFR3|Muenke syndrome|Strong|Autosomal dominant|Genomics England PanelApp","GENCC_000104-HGNC_3690-OMIM_612247-HP_0000006-GENCC_100002|FGFR3|Crouzon syndrome-acanthosis nigricans syndrome|Strong|Autosomal dominant|Genomics England PanelApp","GENCC_000106-HGNC_3690-OMIM_100800-HP_0000006-GENCC_100002|FGFR3|achondroplasia|Strong|Autosomal dominant|Labcorp Genetics (formerly Invitae)","GENCC_000106-HGNC_3690-OMIM_146000-HP_0000006-GENCC_100002|FGFR3|hypochondroplasia|Strong|Autosomal dominant|Labcorp Genetics (formerly Invitae)","GENCC_000106-HGNC_3690-OMIM_149730-HP_0000006-GENCC_100004|FGFR3|LADD syndrome 1|Limited|Autosomal dominant|Labcorp Genetics (formerly Invitae)","GENCC_000106-HGNC_3690-OMIM_187601-HP_0000006-GENCC_100002|FGFR3|thanatophoric dysplasia type 2|Strong|Autosomal dominant|Labcorp Genetics (formerly Invitae)","GENCC_000106-HGNC_3690-OMIM_602849-HP_0000006-GENCC_100002|FGFR3|Muenke syndrome|Strong|Autosomal dominant|Labcorp Genetics (formerly Invitae)","GENCC_000106-HGNC_3690-OMIM_610474-HP_0000006-GENCC_100002|FGFR3|camptodactyly-tall stature-scoliosis-hearing loss syndrome|Strong|Autosomal dominant|Labcorp Genetics (formerly Invitae)","GENCC_000106-HGNC_3690-OMIM_610474-HP_0000007-GENCC_100004|FGFR3|camptodactyly-tall stature-scoliosis-hearing loss syndrome|Limited|Autosomal recessive|Labcorp Genetics (formerly Invitae)","GENCC_000106-HGNC_3690-OMIM_612247-HP_0000006-GENCC_100002|FGFR3|Crouzon syndrome-acanthosis nigricans syndrome|Strong|Autosomal dominant|Labcorp Genetics (formerly Invitae)","GENCC_000106-HGNC_3690-OMIM_616482-HP_0000006-GENCC_100002|FGFR3|severe achondroplasia-developmental delay-acanthosis nigricans syndrome|Strong|Autosomal dominant|Labcorp Genetics (formerly Invitae)","GENCC_000110-HGNC_3690-ORPHANET_15-HP_0000006-GENCC_100009|FGFR3|achondroplasia|Supportive|Autosomal dominant|Orphanet","GENCC_000110-HGNC_3690-ORPHANET_1860-HP_0000006-GENCC_100009|FGFR3|thanatophoric dysplasia type 1|Supportive|Autosomal dominant|Orphanet","GENCC_000110-HGNC_3690-ORPHANET_2363-HP_0000006-GENCC_100009|FGFR3|LADD syndrome|Supportive|Autosomal dominant|Orphanet","GENCC_000110-HGNC_3690-ORPHANET_35098-HP_0000006-GENCC_100009|FGFR3|isolated plagiocephaly|Supportive|Autosomal dominant|Orphanet","GENCC_000110-HGNC_3690-ORPHANET_35099-HP_0000006-GENCC_100009|FGFR3|isolated brachycephaly|Supportive|Autosomal dominant|Orphanet","GENCC_000110-HGNC_3690-ORPHANET_429-HP_0000006-GENCC_100009|FGFR3|hypochondroplasia|Supportive|Autosomal dominant|Orphanet","GENCC_000110-HGNC_3690-ORPHANET_53271-HP_0000006-GENCC_100009|FGFR3|Muenke syndrome|Supportive|Autosomal dominant|Orphanet","GENCC_000110-HGNC_3690-ORPHANET_85164-HP_0000006-GENCC_100009|FGFR3|camptodactyly-tall stature-scoliosis-hearing loss syndrome|Supportive|Autosomal dominant|Orphanet","GENCC_000110-HGNC_3690-ORPHANET_85165-HP_0000006-GENCC_100009|FGFR3|severe achondroplasia-developmental delay-acanthosis nigricans syndrome|Supportive|Autosomal dominant|Orphanet","GENCC_000110-HGNC_3690-ORPHANET_93262-HP_0000006-GENCC_100009|FGFR3|Crouzon syndrome-acanthosis nigricans syndrome|Supportive|Autosomal dominant|Orphanet","GENCC_000110-HGNC_3690-ORPHANET_93274-HP_0000006-GENCC_100009|FGFR3|thanatophoric dysplasia type 2|Supportive|Autosomal dominant|Orphanet","GENCC_000112-HGNC_3690-OMIM_100800-HP_0000006-GENCC_100001|FGFR3|achondroplasia|Definitive|Autosomal dominant|G2P","GENCC_000112-HGNC_3690-OMIM_146000-HP_0000006-GENCC_100001|FGFR3|hypochondroplasia|Definitive|Autosomal dominant|G2P","GENCC_000112-HGNC_3690-OMIM_187600-HP_0000006-GENCC_100001|FGFR3|thanatophoric dysplasia type 1|Definitive|Autosomal dominant|G2P","GENCC_000112-HGNC_3690-OMIM_187601-HP_0000006-GENCC_100001|FGFR3|thanatophoric dysplasia type 2|Definitive|Autosomal dominant|G2P","GENCC_000112-HGNC_3690-OMIM_602849-HP_0000006-GENCC_100001|FGFR3|Muenke syndrome|Definitive|Autosomal dominant|G2P","GENCC_000112-HGNC_3690-OMIM_610474-HP_0000006-GENCC_100001|FGFR3|camptodactyly-tall stature-scoliosis-hearing loss syndrome|Definitive|Autosomal dominant|G2P","GENCC_000112-HGNC_3690-OMIM_612247-HP_0000006-GENCC_100001|FGFR3|Crouzon syndrome-acanthosis nigricans syndrome|Definitive|Autosomal dominant|G2P","GENCC_000112-HGNC_3690-OMIM_620192-HP_0000006-GENCC_100001|FGFR3|lacrimoauriculodentodigital syndrome 2|Definitive|Autosomal dominant|G2P"]}]}